We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$43.4B
AUM Growth
+$3.14B
Cap. Flow
-$115M
Cap. Flow %
-0.27%
Top 10 Hldgs %
13.22%
Holding
2,192
New
164
Increased
795
Reduced
936
Closed
172

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$189M
2
WMB icon
Williams Companies
WMB
+$155M
3
AYX
Alteryx Inc
AYX
+$94.1M
4
ABBV icon
AbbVie
ABBV
+$87M
5
AMGN icon
Amgen
AMGN
+$78.1M

Sector Composition

Rank Sector Weight
1 Technology 17.44%
2 Healthcare 17.1%
3 Financials 12.78%
4 Industrials 10.38%
5 Consumer Discretionary 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FWRG icon
226
First Watch Restaurant Group
FWRG
$700M
$48.8M 0.11%
1,980,300
+200,000
+11% +$4.53M
CCI icon
227
Crown Castle
CCI
$31.6B
$48.3M 0.11%
456,184
-213,626
-32% -$23.2M
KRC icon
228
Kilroy Realty
KRC
$4.06B
$48.2M 0.11%
1,324,207
+33,042
+3% +$1.22M
ACN icon
229
Accenture
ACN
$119B
$48.2M 0.11%
139,012
-68,509
-33% -$25M
IQV icon
230
IQVIA
IQV
$43.1B
$48M 0.11%
189,695
+18,170
+11% +$4.24M
WB icon
231
Weibo
WB
$1.63B
$48M 0.11%
5,276,695
-13,931
-0.3% -$126K
GS icon
232
Goldman Sachs
GS
$288B
$47.7M 0.11%
114,257
-1,670
-1% -$648K
COLD icon
233
Americold
COLD
$4.17B
$47.5M 0.11%
1,905,159
-206,834
-10% -$5.65M
VERV
234
DELISTED
Verve Therapeutics
VERV
$47.2M 0.11%
3,556,577
-423,795
-11% -$5.62M
PEGA icon
235
Pegasystems
PEGA
$6.36B
$46.6M 0.11%
1,441,980
-135,852
-9% -$3.81M
ONON icon
236
On Holding
ONON
$9.18B
$46.5M 0.11%
1,313,615
+758,615
+137% +$23.2M
AIT icon
237
Applied Industrial Technologies
AIT
$11.9B
$46.4M 0.11%
235,066
+45,041
+24% +$8.23M
GAP
238
The Gap Inc
GAP
$7.35B
$46.4M 0.11%
1,685,324
-163,098
-9% -$3.44M
TDG icon
239
TransDigm Group
TDG
$61.4B
$46M 0.11%
37,349
+1,528
+4% +$1.72M
MMS icon
240
Maximus
MMS
$2.98B
$45.8M 0.11%
546,315
+4,462
+0.8% +$367K
PODD icon
241
Insulet
PODD
$9.56B
$45.6M 0.1%
265,847
+80,500
+43% +$15M
LRCX icon
242
Lam Research
LRCX
$342B
$45.6M 0.1%
468,920
-70,660
-13% -$6.22M
AMN icon
243
AMN Healthcare
AMN
$1.29B
$44.9M 0.1%
718,692
+23,425
+3% +$1.59M
ONT
244
Onterris Inc
ONT
$644M
$44.7M 0.1%
1,140,500
SMAR
245
DELISTED
Smartsheet Inc.
SMAR
$44.5M 0.1%
1,155,418
+228,418
+25% +$9.97M
APAM icon
246
Artisan Partners
APAM
$2.69B
$44.4M 0.1%
970,319
-410
-0% -$17.6K
PEG icon
247
Public Service Enterprise Group
PEG
$36.1B
$43.5M 0.1%
652,038
-649,740
-50% -$39.8M
STZ icon
248
Constellation Brands
STZ
$21.3B
$43.4M 0.1%
159,824
-4,828
-3% -$1.22M
PCOR icon
249
Procore
PCOR
$8.09B
$43.3M 0.1%
526,366
+296,725
+129% +$22M
UL icon
250
Unilever
UL
$137B
$43.2M 0.1%
764,594
-512,473
-40% -$28.4M

Similar funds

Federated Hermes's Q1 2024 Portfolio in Review

As of Q1 2024, Federated Hermes held 2,192 positions worth $43.4B, up 7.8% from $40.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Federated Hermes's Q1 2024 filing shows 164 new, 795 increased, 936 reduced and 172 closed positions. Its largest new stake was Kanzhun: 4,861,533 shares worth $85.2M. The largest sale was Medtronic, an estimated $189M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Federated Hermes's largest Q1 2024 buy was Kanzhun: 4,861,533 shares worth $85.2M.
  • Federated Hermes added most to Bristol-Myers Squibb in Q1 2024, an estimated $193M increase.
  • Federated Hermes's biggest Q1 2024 reduction was Medtronic, cutting an estimated $189M.
  • Federated Hermes fully exited Alteryx Inc in Q1 2024, selling an estimated $94.1M.
  • Federated Hermes's ten largest holdings make up 13% of its $43.4B portfolio in Q1 2024.
  • Federated Hermes opened 164 new positions and closed 172 in Q1 2024.
  • Federated Hermes's portfolio value rose 7.8% quarter-over-quarter to $43.4B.

Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.